EIGER GROUP INTERNATIONAL, INC.
Biotech · Private
Clemizole, a repurposed first-generation antihistamine, developed as a low-cost therapeutic for hepatocellular carcinoma (HCC)
- Grants
- $267K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 2 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC) | $267,105 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2677 | Forkhead Biotherapeutics, Inc. | — | — |
| 2678 | Arcus, Inc. | — | $35K |
| 2679 | Extended Longevity, Inc. | — | $10K |
| 2680 | EIGER GROUP INTERNATIONAL, INC. | — | — |
| 2681 | MOLECULAR WORLD HEALTH, INC. | — | $5K |
| 2682 | THINK THERAPEUTICS, INC. | — | — |
| 2683 | Integrated Biotherapeutic Vaccines, Inc. | — | $3K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Use of Chloroquine Compounds for Treatment of Inflammatory Conditionsapplication
- Use of Clemizole Compounds for Treatment of Inflammatory Conditionsgranted
- Use of Chloroquine and Clemizole Compounds for Treatment of Inflammatory and Cancerous Conditionsgranted
- Use Of Chloroquine And Clemizole Compounds For Treatment Of Inflammatory And Cancerous Conditionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.